University of California - San Diego Oct 16 2024 Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer has the potential to be an effective therapeutic for a specific type of appendix cancer.  The clinical trial results, publishing in the October 16, 2024 online edition of the Journal of Clinical Oncology , showed the oral medication, known as palbociclib, stabilized tumor growth and reduced blood tumor marker levels in